Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Kocić, J; Santibañez, JF; Krstić, A; Mojsilović, S; Dorđević, IO; Trivanović, D; Ilić, V; Bugarski, D.
Interleukin 17 inhibits myogenic and promotes osteogenic differentiation of C2C12 myoblasts by activating ERK1,2.
Biochim Biophys Acta. 2012; 1823(4): 838-849.
PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Krstic Jelena

Dimensions Citations:

Plum Analytics:
The present study evaluated the role of interleukin (IL) 17 in multilineage commitment of C2C12 myoblastic cells and investigated associated signaling pathways. The results concerning the effects on cell function showed that IL-17 inhibits the migration of C2C12 cells, while not affecting their proliferation. The data regarding the influence on differentiation demonstrated that IL-17 inhibits myogenic differentiation of C2C12 cells by down-regulating the myogenin mRNA level, myosin heavy chain expression and myotube formation, but promotes their osteogenic differentiation by up-regulating the Runt-related transcription factor 2 mRNA level, cyclooxygenase-2 expression and alkaline phosphatase activity. IL-17 exerted these effects by activating ERK1,2 mitogen activated protein kinase signaling pathway, which in turn regulated the expression of relevant genes and proteins to inhibit myogenic differentiation and induce osteogenic differentiation. Additional analysis showed that the induction of osteogenic differentiation by IL-17 is independent of BMP signaling. The results obtained demonstrate the potential of IL-17 not only to inhibit the myogenic differentiation of C2C12 myoblasts but also to convert their differentiation pathway into that of osteoblast lineage providing new insight into the capacities of IL-17 to modulate the differentiation commitment. Copyright © 2012 Elsevier B.V. All rights reserved.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Bone Morphogenetic Proteins - metabolism
Cell Differentiation - drug effects
Cell Line -
Cell Movement - drug effects
Cell Proliferation - drug effects
Enzyme Activation - drug effects
Interleukin-17 - pharmacology
MAP Kinase Signaling System - drug effects
Mice -
Mitogen-Activated Protein Kinase 1 - metabolism
Mitogen-Activated Protein Kinase 3 - metabolism
Models, Biological -
Muscle Development - drug effects
Myoblasts - cytology
Myoblasts - drug effects
Myoblasts - enzymology
Osteogenesis - drug effects
Receptors, Interleukin-17 - metabolism

© Meduni Graz Impressum